BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31186404)

  • 41. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D; Lu G; Shao Y; Xu D
    Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
    Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
    Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
    Yang Y; Yuan Y; Xia B
    Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
    Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
    Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-6838-5p Affects Cell Growth, Migration, and Invasion by Targeting GPRIN3 via the Wnt/β-Catenin Signaling Pathway in Gastric Cancer.
    Zhou W; Ding X; Jin P; Li P
    Pathobiology; 2020; 87(6):327-337. PubMed ID: 33254176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
    Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
    Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL; Liang S; Cui JH; Han GY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Peng Y; Zhang X; Ma Q; Yan R; Qin Y; Zhao Y; Cheng Y; Yang M; Wang Q; Feng X; Huang Y; Huang W; Zhao Z; Wang L; Wei Y; He Z; Fan X; Li S; Jin Z; Meltzer SJ
    Cancer Lett; 2017 Jan; 385():117-127. PubMed ID: 27810403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway.
    Dai X; Liu J; Guo X; Cheng A; Deng X; Guo L; Wang Z
    Clin Sci (Lond); 2020 Jul; 134(13):1821-1839. PubMed ID: 32633323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
    BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-375-3p/YWHAZ/β-catenin axis regulates migration, invasion, EMT in gastric cancer cells.
    Guo F; Gao Y; Sui G; Jiao D; Sun L; Fu Q; Jin C
    Clin Exp Pharmacol Physiol; 2019 Feb; 46(2):144-152. PubMed ID: 30353914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.